Please login to the form below

Not currently logged in
Email:
Password:

BARDA

This page shows the latest BARDA news and features for those working in and with pharma, biotech and healthcare.

Real-world data highlights flu vaccine efficacy

Real-world data highlights flu vaccine efficacy

The study, which will begin in Q4 2021, will build on the Drive Beyond the Needle collaboration between Enesi and the Biomedical Advanced Research and Development Authority (BARDA) earlier this year,

Latest news

More from news
Approximately 3 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Rethinking our approach to infectious disease preparedness Rethinking our approach to infectious disease preparedness

    Achaogen and Aradigm filed for bankruptcy in 2019, and Melinta did the same at the start of 2020, despite heavy investment from the US Biomedical Advanced Research and Development Authority (BARDA). ... Commendably, BARDA provided funding to bridge the

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    That includes an agreement with the US Biomedical Advanced Research and Development Authority (BARDA) on the development of a recombinant, protein-based vaccine candidate.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    US agencies like BARDA have a long history of supporting these innovative approaches to public health. ... We are conducting a 134-person influenza challenge study, one of the largest ever conducted and co-funded by BARDA, to validate this approach.

  • Deal Watch September 2016 Deal Watch September 2016

    BARDA) has been very busy announcing grants with a range of companies for various development projects. ... The Medicines Co received a BARDA grant of up to $132m for the development of antibiotics against drug-resistant, gram-negative infections.

  • Deal Watch June 2016 Deal Watch June 2016

    BARDA) to support Cerus' clinical development programme for pathogen reduction of red blood cell (RBC) components. ... collaboration, licence. 200. Cerus/ BARDA. Intercept, pathogen reduction technology for blood transfusions including Zika virus.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • What is everyone ‘ARPAing on about?

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and ... But can DARPA, ARPA or BARDA actually deliver

  • Hanover Communications Hanover Communications

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and ... But can DARPA, ARPA or BARDA actually deliver

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....